On July 29th, 2021, Friends of Cancer Research (Friends) hosted a virtual meeting revolving around the recently released 21st Century Cures 2.0 discussion draft. It featured a discussion panel of Representative Diana DeGette (D-CO), Representative Fred Upton (R-MI), Dr. Ned Sharpless, Director of the National Cancer Institute, and Dr. Richard Pazdur, Director of the Oncology Center of Excellence at the U.S. Food and Drug Administration (FDA).

Creating a New Cancer Research Paradigm by Broadening Eligibility Criteria

The American Society of Clinical Oncology (ASCO, a professional society for cancer clinicians and researchers) and Friends of Cancer Research (Friends, a cancer advocacy organization focused on advancing science, policy, and regulation) have been collaborating to promote broader, more inclusive cancer clinical trial eligibility crite

Creating a New Cancer Research Paradigm by Broadening Eligibility Criteria

The American Society of Clinical Oncology (ASCO, a professional society for cancer clinicians and researchers) and Friends of Cancer Research (Friends, a cancer advocacy organization focused on advancing science, policy, and regulation) have been collaborating to promote broader, more inclusive cancer clinical trial eligibility criteria since 2016.

The U.S. Food and Drug Administration (FDA) fulfills its mission to protect and advance the public health by overseeing the development and approval of new medical products and ensuring that they are safe and effective for American consumers. When taking into consideration the full range of products the FDA oversees, including not just medical products, but food, cosmetics, veterinary and tobacco products, it has been estimated that the FDA is responsible for regulating one-fifth of all consumer spending in the US.

I was 18 when my life was turned upside down by cancer. My mother was diagnosed with a highly aggressive malignancy after a colonoscopy due to a flair-up of Crohn’s disease. She spent the next two months in the hospital after the surgery to remove the malignancy left her near death with adhesions, requiring a second, corrective surgery, and a long recovery.

 

To this day, I don’t really understand how my family held it together and, even though my mom has been cancer free for more than 10 years now, that experience has impacted everything that I have done since.

Subscribe to NIH